[1
]
From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres,
C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.),
NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics
and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany;
and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences,
University of Oxford, Oxford, United Kingdom (P.M.R.). hebun.erdur@charite.de.
[2
]
From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres,
C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.),
NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics
and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany;
and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences,
University of Oxford, Oxford, United Kingdom (P.M.R.).